Orange Book product · Brand (NDA)
CALCIMAR
CALCITONIN SALMON
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
CALCITONIN SALMON
Strength
400 IU/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
NDA 017497
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 1995MIACALCINBrand (NDA)
NDA 020313 · PHARMOBEDIENT
- 1986MIACALCINBrand (NDA)
NDA 017808 · MYLAN IRELAND LTD
- —CALCIMARBrand (NDA)
NDA 017769 · SANOFI AVENTIS US
- 2026CALCITONIN-SALMONGeneric (ANDA)
ANDA 215864 · ZYDUS PHARMS
- 2025CALCITONIN-SALMONGeneric (ANDA)
ANDA 216294 · AMNEAL
- 2025CALCITONIN-SALMONGeneric (ANDA)
ANDA 219196 · SAGENT
- 2024CALCITONIN-SALMONGeneric (ANDA)
ANDA 212675 · FRESENIUS KABI USA
- 2024CALCITONIN-SALMONGeneric (ANDA)
ANDA 213766 · CIPLA
- 2024CALCITONIN-SALMONGeneric (ANDA)
ANDA 215715 · DR REDDYS
- 2021CALCITONIN-SALMONGeneric (ANDA)
ANDA 209358 · PH HEALTH
- 2021CALCITONIN-SALMONGeneric (ANDA)
ANDA 212416 · CUSTOPHARM INC
- 2009CALCITONIN-SALMONGeneric (ANDA)
ANDA 076979 · PH HEALTH
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
